Stock MTEM MOLECULAR TEMPLATES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Molecular Templates, Inc.

Equities

MTEM

US6085502085

Delayed Nasdaq
Other stock markets
 01:52:24 2024-05-22 pm EDT 		5-day change 1st Jan Change
1.34 USD -1.47% Intraday chart for Molecular Templates, Inc. -7.59% -64.08%
May. 15 Earnings Flash (MTEM) MOLECULAR TEMPLATES Posts Q1 Revenue $11.1M MT
Apr. 12 Molecular Templates, Inc. Announces Cessation of Maurizio Voi as Chief Medical Officer, Effective April 30, 2024 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Earnings Flash (MTEM) MOLECULAR TEMPLATES Posts Q1 Revenue $11.1M
MT
Molecular Templates, Inc. Reports First Quarter 2024 Financial Results and Corporate Update
AQ
Molecular Templates, Inc. Announces Cessation of Maurizio Voi as Chief Medical Officer, Effective April 30, 2024
CI
Molecular Templates Presents Interim Data from MT-6402 Phase I Study in Patients with PD-L1+ Solid Tumors at the 2024 American Association for Cancer Research (AACR) Annual Meeting; Monotherapy Activity in Checkpoint-Experienced Head and Neck Cancer Patients Observed Through Novel Immuno-oncology Mechanism
AQ
Molecular Templates, Inc. Presents Interim Data from Mt-6402 Phase I Study in Patients with Pd-L1+ Solid Tumors At the 2024 American Association for Cancer Research Annual Meeting
CI
Molecular Templates, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update
AQ
Molecular Templates, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second Tranche of July 2023 Purchase Agreement
AQ
North American Morning Briefing: Investors Balance AI Hopes with Rate Concerns
DJ
Molecular Templates, Inc. Provides Interim Update
AQ
Molecular Templates, Inc. Provides Interim Update
CI
Molecular Templates to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference
AQ
Molecular Templates, Inc. Announces Board Changes
CI
Molecular Templates, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Earnings Flash (MTEM) MOLECULAR TEMPLATES Reports Q3 Revenue $6.8M
MT
Molecular Templates, Inc. Reports Third Quarter 2023 Financial Results and Business Update
AQ
Molecular Templates Announces First Patient Dosed in Phase 1 Trial Evaluating MT-8421, a Novel Engineered Toxin Body Targeting CTLA-4, in Advanced Solid Tumors
AQ
Molecular Templates, Inc. Announces First Patient Dosed in Phase 1 Trial Evaluating MT-8421, a Novel Engineered Toxin Body Targeting CTLA-4, in Advanced Solid Tumors
CI
Molecular Templates to Participate in Upcoming Investor Conferences
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MTEM Stock
  4. News Molecular Templates, Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW